Clinical trial
Eligibility Screening of Patients With Central Nervous System Tumors for the…
NCT00035373 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00035373 |
|---|---|
| Title | Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols |
| Official title | Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute (NCI) Clinical Research Protocols |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Study type | Observational |
| Conditions | Glioblatoma, Gliosarcoma, Anaplastic Astrocytoma, Oligodendroglioma, Anaplastic Oligoastrocytoma |
| Enrollment | 767 |
| Start date | Apr 19, 2002 |
| Completion | Apr 29, 2015 |
| First posted | May 3, 2002 |
| Last update posted | Nov 7, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: